Connor, Clark & Lunn Investment Management (CC&L)’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.1M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $942K | Sell |
|
|||||
|
2023
Q4 | $1.15M | Sell |
|
|||||
|
2023
Q3 | $2.94M | Buy |
|
|||||
|
2023
Q2 | $1.83M | Buy |
|
|||||
|
2023
Q1 | $1.4M | Buy |
|
|||||
|
2022
Q4 | $898K | Sell |
|
|||||
|
2022
Q3 | $712K | Buy |
|
|||||
|
2022
Q2 | $771K | Buy |
|
|||||
|
2022
Q1 | $462K | Sell |
|
|||||
|
2021
Q4 | $4.08M | Buy |
|
|||||
|
2021
Q3 | $3.24M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $1.82M | Buy |
|
|||||
|
2020
Q4 | $1.53M | Sell |
|
|||||
|
2020
Q3 | $3.77M | Sell |
|
|||||
|
2020
Q2 | $5.67M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $234K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $524K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $990K | Sell |
|
|||||
|
2015
Q4 | $2.32M | Sell |
|
|||||
|
2015
Q3 | $4.54M | Buy |
|
|||||
|
2015
Q2 | $1.48M | Sell |
|
|||||
|
2015
Q1 | $2.18M | Sell |
|
|||||
|
2014
Q4 | $2.33M | Sell |
|
|||||
|
2014
Q3 | $6.26M | Buy |
|
|||||
|
2014
Q2 | $5.34M | Buy |
|
|||||
|
2014
Q1 | $471K | Sell |
|
|||||
|
2013
Q4 | $783K | Buy |
|